In the tumor landscape, one of the first indications that AnxA1 could promote immune escape came from experiments in which AnxA1 was knocked down in a glioblastoma multiforme animal model and caused decreased tumor growth and myeloid infiltration. Here, ANXA1 is linked to glioblastoma.